Markets:

Overview

News

Currencies

International

Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.8369 +0.0120 (+1.45%)

Streaming Delayed Price Updated: 11:42 AM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

7 Short-Squeeze Stocks to Buy Before They Soar ↗

January 30, 2023

If you’re hunting for bears, you’re going to need the right equipment. Targeting these compelling short-squeeze stocks to buy might help.

Via InvestorPlace

Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday ↗

January 23, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Oragenics's Return On Capital Employed Insights ↗

December 27, 2022

Via Benzinga

Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday ↗

December 27, 2022

With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Oragenics, Inc. Discloses One-for-Sixty Reverse Stock Split

December 23, 2022

From Oragenics, Inc.

Via Business Wire

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate ↗

December 22, 2022

Via Benzinga

Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate

December 22, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics, Inc. Receives NYSE American Notice

December 20, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics, Inc. Announces New Chair

December 19, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics to Participate in the 2022 BioFlorida Annual Conference

October 24, 2022

From Oragenics, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 20, 2022

It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 04, 2022

Friday's session saw 236 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Oragenics Issues Letter to Shareholders

September 30, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate

August 24, 2022

From Oragenics, Inc.

Via Business Wire

Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket ↗

August 24, 2022

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities.

Via Benzinga

Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer

June 23, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports

June 14, 2022

From Oragenics, Inc

Via Business Wire

Oragenics Issues Letter to Shareholders

May 17, 2022

From Oragenics, Inc.

Via Business Wire

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Oragenics's Earnings: A Preview ↗

April 26, 2022

Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will...

Via Benzinga

Oragenics to Participate at the World Vaccine Congress Washington 2022

April 18, 2022

From Oragenics, Inc.

Via Business Wire

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

Oragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses

April 06, 2022

From Oragenics, Inc.

Via Business Wire

68 Biggest Movers From Yesterday ↗

April 05, 2022

Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...

Via Benzinga

Executives Buy Around $5.5M Of 3 Penny Stocks ↗

April 04, 2022

US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

March 31, 2022

US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation

March 25, 2022

From Oragenics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oragenics Inc. Common Stock (NY:OGEN)

All News about Oragenics Inc. Common Stock

Starting at $3.75/week.

Subscribe Today